European cancer vaccine startup Nouscom poaches Pfizer IO executive – FierceBiotech

FierceBiotech
This latest personnel addition is a nice poach for the small startup, which can lean on Woolfson’s experience at the Big Pharma for building a portfolio of monotherapy and combo studies for Pfizer’s PD-L1 inhibitor Bavencio and 4-1BB agonist utomilumab …

and more

…read more

Source:: Startup Tech News From Google News

Leave a Comment